Follow
Vivek Patel
Vivek Patel
Resident, Harvard Radiation Oncology Program
Verified email at partners.org
Title
Cited by
Cited by
Year
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia
VL Patel, M Mahévas, SY Lee, R Stasi, S Cunningham-Rundles, ...
Blood, The Journal of the American Society of Hematology 119 (25), 5989-5995, 2012
4262012
Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura
J Yu, S Heck, V Patel, J Levan, Y Yu, JB Bussel, K Yazdanbakhsh
Blood, The Journal of the American Society of Hematology 112 (4), 1325-1328, 2008
2922008
ZBP1 recognition of β-actin zipcode induces RNA looping
JA Chao, Y Patskovsky, V Patel, M Levy, SC Almo, RH Singer
Genes & development 24 (2), 148-158, 2010
2202010
Spatial arrangement of an RNA zipcode identifies mRNAs under post-transcriptional control
VL Patel, S Mitra, R Harris, AR Buxbaum, T Lionnet, M Brenowitz, M Girvin, ...
Genes & development 26 (1), 43-53, 2012
1622012
Coronary access after TAVR
T Ochiai, T Chakravarty, SH Yoon, D Kaewkes, N Flint, V Patel, S Mahani, ...
Cardiovascular Interventions 13 (6), 693-705, 2020
1282020
Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration
JB Bussel, CS Lee, C Seery, AA Imahiyerobo, MV Thompson, D Catellier, ...
Haematologica 99 (7), 1264, 2014
1092014
The effect of anti‐CD40 ligand in immune thrombocytopenic purpura
VL Patel, J Schwartz, JB Bussel
British journal of haematology 141 (4), 545-548, 2008
902008
Human antimicrobial peptides LL‐37 and human β‐defensin‐2 reduce viral replication in keratinocytes infected with varicella zoster virus
LR Crack, L Jones, GN Malavige, V Patel, GS Ogg
Clinical and experimental dermatology 37 (5), 534-543, 2012
862012
Suspension matrices for improved Schwann-cell survival after implantation into the injured rat spinal cord
V Patel, G Joseph, A Patel, S Patel, D Bustin, D Mawson, LM Tuesta, ...
Journal of neurotrauma 27 (5), 789-801, 2010
862010
Repeated courses of rituximab in chronic ITP: three different regimens
A Hasan, M Michel, V Patel, R Stasi, S Cunningham‐Rundles, ...
American journal of hematology 84 (10), 661-665, 2009
832009
Coronary protection to prevent coronary obstruction during TAVR: a multicenter international registry
T Palmerini, T Chakravarty, F Saia, AG Bruno, ML Bacchi-Reggiani, ...
Cardiovascular Interventions 13 (6), 739-747, 2020
672020
Lipid-based oral formulation strategies for lipophilic drugs
V Patel, R Lalani, D Bardoliwala, S Ghosh, A Misra
Aaps Pharmscitech 19 (8), 3609-3630, 2018
562018
Synergistic effect of organic and inorganic nano fillers on the dielectric and mechanical properties of epoxy composites
M Khan, AA Khurram, T Li, T Zhao, T Subhani, IH Gul, Z Ali, V Patel
Journal of Materials Science & Technology 34 (12), 2424-2430, 2018
502018
The structural basis for RNA selectivity by the IMP family of RNA-binding proteins
J Biswas, VL Patel, V Bhaskar, JA Chao, RH Singer, C Eliscovich
Nature communications 10 (1), 4440, 2019
412019
Combinatorial nanocarriers against drug resistance in hematological cancers: opportunities and emerging strategies
S Ghosh, R Lalani, V Patel, D Bardoliwala, K Maiti, S Banerjee, ...
Journal of controlled release 296, 114-139, 2019
392019
Global carbon nanotubes market-industry beckons
V Patel
Nanowerk: Honolulu, HI, 2011
392011
Colloidally stable small unilamellar stearyl amine lipoplexes for effective BMP-9 gene delivery to stem cells for osteogenic differentiation
I Vhora, R Lalani, P Bhatt, S Patil, H Patel, V Patel, A Misra
AAPS PharmSciTech 19, 3550-3560, 2018
382018
Hydroxyethyl substituted linear polyethylenimine for safe and efficient delivery of siRNA therapeutics
S Patil, R Lalani, P Bhatt, I Vhora, V Patel, H Patel, A Misra
RSC advances 8 (62), 35461-35473, 2018
372018
Antimicrobial peptide delivery: an emerging therapeutic for the treatment of burn and wounds
A Javia, J Amrutiya, R Lalani, V Patel, P Bhatt, A Misra
Therapeutic delivery 9 (5), 375-386, 2018
352018
Long term follow-up of patients with immune thrombocytopenic purpura (ITP) whose initial response to rituximab lasted a minimum of 1 year.
V Patel, N Mihatov, N Cooper, R Stasi, S Cunningham-Rundles, ...
Blood 108 (11), 479, 2006
342006
The system can't perform the operation now. Try again later.
Articles 1–20